Who
Lars Holtug
Director
Company insider
Files Form 4 as: Director, Ascendis Pharma A/S.
In numbers
- Trades disclosed
- 2
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $125K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 2 Sep 2026
- Last trade
- 2 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 3 Sep 2026 | ASND Ascendis Pharma A/SBiotechnology | SEC FORM 4 Sold | $62K236 at $264.13 | filing |
| 2 Sep 2026filed 3 Sep 2026 | ASND Ascendis Pharma A/SBiotechnology | SEC FORM 4 Sold | $62K236 at $264.13 | filing |
News
Head-To-Head Survey: Avalo Therapeutics (NASDAQ:AVTX) & Ascendis Pharma A/S (NASDAQ:ASND)ASND · themarketsdaily.com · 22 Oct 2026Ascendis Pharma A/S (NASDAQ:ASND) vs. Rigel Pharmaceuticals (NASDAQ:RIGL) Head-To-Head ReviewASND · tickerreport.com · 21 Oct 2026
0 headlines in the last 90 days name Lars Holtug; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.